Heparin-induced thrombocytopenia
MONDO:0018048Heparin-induced thrombocytopenia (HIT) is a drug-induced, immune-mediated prothrombotic disorder associated with thrombocytopenia and venous and/or arterial thrombosis.
Also known as: HAT, HIT, heparin-associated thrombocytopenia, heparin-induced thrombocytopenia, heparin-induced thrombocytopenia (disease), heparin-induced thrombocytopenia type 2
9 clinical trials for this condition and its sub-types, 5 tagged with Heparin-induced thrombocytopenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Radioactive tracer lights up blood clots on scans
Diagnosis Recruiting nowResearchers are testing a radioactive tracer called 18F/68Ga-GP1 that binds to a protein found on blood clots. Adults with suspected, newly diagnosed, or previously treated thrombi receive one intravenous injection and then undergo PET/CT or MRI imaging. The study measures how mu…
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Massive study aims to unravel mysteries of blood clots and vessel disease
Knowledge-focused Recruiting nowThis study aims to learn more about how diseases related to blood clots, the immune system, and blood vessels start and change over time. Researchers will enroll up to 1,000 people aged 5 and older, including those with these conditions, their healthy relatives, and healthy volun…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC